NL7006077A - - Google Patents

Info

Publication number
NL7006077A
NL7006077A NL7006077A NL7006077A NL7006077A NL 7006077 A NL7006077 A NL 7006077A NL 7006077 A NL7006077 A NL 7006077A NL 7006077 A NL7006077 A NL 7006077A NL 7006077 A NL7006077 A NL 7006077A
Authority
NL
Netherlands
Application number
NL7006077A
Other versions
NL167438C (nl
NL167438B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH691269A external-priority patent/CH530374A/de
Application filed filed Critical
Publication of NL7006077A publication Critical patent/NL7006077A/xx
Publication of NL167438B publication Critical patent/NL167438B/xx
Application granted granted Critical
Publication of NL167438C publication Critical patent/NL167438C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7006077A 1969-05-06 1970-04-27 Werkwijze voor het bereiden van amiden, afgeleid van lysergzuur (of een lysergzuurderivaat) en een peptidisch aminocyclol. NL167438C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH691269A CH530374A (de) 1969-05-06 1969-05-06 Neues Verfahren zur Herstellung von Mutterkornpeptidalkaloiden
CH1011869 1969-07-02

Publications (3)

Publication Number Publication Date
NL7006077A true NL7006077A (is") 1970-11-10
NL167438B NL167438B (nl) 1981-07-16
NL167438C NL167438C (nl) 1981-12-16

Family

ID=25700377

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7006077A NL167438C (nl) 1969-05-06 1970-04-27 Werkwijze voor het bereiden van amiden, afgeleid van lysergzuur (of een lysergzuurderivaat) en een peptidisch aminocyclol.

Country Status (10)

Country Link
BE (1) BE749920A (is")
CS (1) CS152357B2 (is")
DE (1) DE2021706C2 (is")
DK (1) DK132029C (is")
FR (1) FR2047237A5 (is")
GB (1) GB1301346A (is")
HU (1) HU162310B (is")
NL (1) NL167438C (is")
PL (1) PL80563B1 (is")
SE (1) SE382634B (is")

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH601321A5 (is") * 1975-01-06 1978-07-14 Sandoz Ag

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2736728A (en) * 1954-12-06 1956-02-28 Lilly Co Eli Preparation of lysergic acid amides
US2997470A (en) * 1956-03-05 1961-08-22 Lilly Co Eli Lysergic acid amides

Also Published As

Publication number Publication date
SE382634B (sv) 1976-02-09
DK132029B (da) 1975-10-13
GB1301346A (is") 1972-12-29
NL167438C (nl) 1981-12-16
CS152357B2 (is") 1973-12-19
BE749920A (fr) 1970-11-04
DE2021706C2 (de) 1983-08-25
NL167438B (nl) 1981-07-16
DK132029C (da) 1976-03-01
PL80563B1 (is") 1975-08-30
DE2021706A1 (de) 1970-11-19
FR2047237A5 (is") 1971-03-12
HU162310B (is") 1973-01-29

Similar Documents

Publication Publication Date Title
AU2270770A (is")
AU465413B2 (is")
AU429630B2 (is")
AU5461069A (is")
AU2355770A (is")
AU442375B2 (is")
AU470301B1 (is")
AU427401B2 (is")
HU162310B (is")
AU428129B2 (is")
AU428131B2 (is")
AU438128B2 (is")
AU414607B2 (is")
AU442322B2 (is")
AU425297B2 (is")
AU442285B2 (is")
AU442357B2 (is")
AT308690B (is")
AU428074B2 (is")
AU442535B2 (is")
AU442380B2 (is")
AU5079269A (is")
CS148416B1 (is")
CS149918B2 (is")
AR203167Q (is")

Legal Events

Date Code Title Description
V4 Lapsed because of reaching the maxim lifetime of a patent